Skip to content

Price / sales at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
6.1×+1.6×
Glaukos logo
GlaukosGKOS
11.3×-2.4×
AbbVie logo
AbbVieABBV
6.1×-0.3×
Bausch + Lomb logo
Bausch + LombBLCO
1.1×0.0×
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
5.6×-3.5×
Boston Scientific logo
Boston ScientificBSX
4.5×-4.0×

Other financials

Income statement

See full
Revenue$19.7M+12.5%
Gross profit$17.0M+12.5%
Operating income-$12.4M+10.4%
Net income-$13.0M+8.3%
EPS (diluted)-$0.24+14.3%

Balance sheet

See full
Cash & equivalents$85.0M-21.9%
Total debt$40.9M+1.1%
Total equity$53.9M-30.6%
Total assets$109.7M-15.4%

Cash flow

See full
Operating cash flow-$7.0M+39.4%
CapEx$60.0K
Free cash flow-$7.1M+38.9%

Valuation

See full
Market cap$294.9M+35.0%
Enterprise value$250.83M+59.0%

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin-44.8%-10.2pp
Net margin-46.8%-9.6pp
FCF margin-31.9%+0.2pp

Returns & leverage

See full
Return on equity-56.6%+4.3pp
Debt / equity0.8×+0.2×
Current ratio5.9×-4.6×

Where this comes from

Calculated from Sight Sciences, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Sight Sciences, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sight Sciences, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sight Sciences, Inc.'s price / sales?
Sight Sciences, Inc. (SGHT) reported price / sales of 2.6× in Q1 2026.
How has Sight Sciences, Inc.'s price / sales changed year-over-year?
Sight Sciences, Inc.'s price / sales increased by 62.3% year-over-year, from 1.6× to 2.6×.
What is the long-term trend for Sight Sciences, Inc.'s price / sales?
Over 4 years (2021 to 2025), Sight Sciences, Inc.'s price / sales has grown at a -24.9% compound annual growth rate (CAGR), from 17.1× to 5.4×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.